Pancreatic Cancer Patient Survival Data After Pancreatectomy, 2016-2020

258 pancreatic cancer patients who underwent pancreatectomy at the First Affiliated Hospital of Xi’an Jiaotong University between February 2016 and December 2020. The dataset includes 96 patients who received adjuvant chemotherapy and 162 who did not, with survival outcomes analyzed by disease stage. It was authored by Lin Zhang and shared under a CC-BY-4.0 license.

Use Cases

• Modeling the impact of adjuvant chemotherapy on overall survival based on patient stage.
• Comparing survival outcomes between early-stage (I) and late-stage (II-IV) disease groups.
• Conducting propensity score matching analysis to control for confounding variables in observational clinical data.
• Validating clinical guidelines for postoperative chemotherapy using real-world hospital data.

Strengths

• Includes detailed survival metrics: median overall survival was 14.9 months, with a median follow-up of 36.5 months.
• Provides stage-specific analysis with statistically significant results for late-stage disease (HR 0.59; 95% CI 0.38–0.91).
• Uses propensity score matching to minimize intergroup differences in the retrospective cohort.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data reflects a single hospital's patient population, which may introduce geographic or institutional bias.

Provenance

Source

First Affiliated Hospital of Xi’an Jiaotong University

Collection Method

Retrospective analysis of clinical data from patients who underwent pancreatectomy.

Time Range

February 2016 to December 2020

Freshness

Last updated 2026-04-13 04:34:40; freshness should be verified.

Geography

Likely China, based on the hospital location.